Showing results (131-140 of 155) with videos related to

Sort By:
Pageof 16
Clinical Rheumatology|January 30, 2021
Drug retention of sarilumab, baricitinib, and tofacitinib in patients with rheumatoid arthritis: the ANSWER cohort studyKosuke Ebina, Toru Hirano, Yuichi Maeda, et al.
Arthritis Research & Therapy|March 7, 2025
Comparative effectiveness of subcutaneous sarilumab 200 mg biweekly, subcutaneous Tocilizumab 162 mg biweekly, and intravenous Tocilizumab 8 mg/kg every 4 weeks in patients with rheumatoid arthritis: a prospective cohort studyAkira Onishi, Masao Tanaka, Takayuki Fujii, et al.
Rheumatology (Oxford, England)|June 24, 2023
IL-6 inhibitors and JAK inhibitors as favourable treatment options for patients with anaemia and rheumatoid arthritis: ANSWER cohort studyYoichi Nakayama, Ryu Watanabe, Wataru Yamamoto, et al.
Arthritis Research & Therapy|August 5, 2018
Factors associated with the achievement of biological disease-modifying antirheumatic drug-free remission in rheumatoid arthritis: the ANSWER cohort studyMotomu Hashimoto, Moritoshi Furu, Wararu Yamamoto, et al.
International Journal of Molecular Sciences|April 28, 2023
Prognostic Factors Affecting Death in Patients with Rheumatoid Arthritis Complicated by <i>Pneumocystis jirovecii</i> Pneumonia and One-Year Clinical Course: The ANSWER Cohort StudyHideyuki Shiba, Takuya Kotani, Koji Nagai, et al.
Osteoarthritis and Cartilage|August 10, 2023
Basic fibroblast growth factor promotes meniscus regeneration through the cultivation of synovial mesenchymal stem cells via the CXCL6-CXCR2 pathwayAtsushi Goshima, Yuki Etani, Makoto Hirao, et al.
Modern Rheumatology|August 13, 2022
Add-on effectiveness of methotrexate or iguratimod in patients with rheumatoid arthritis exhibiting an inadequate response to Janus kinase inhibitors: The ANSWER cohort studyKosuke Ebina, Toru Hirano, Yuichi Maeda, et al.
Journal of Bone and Mineral Metabolism|March 28, 2024
The 2023 Guidelines for the management and treatment of glucocorticoid-induced osteoporosisYoshiya Tanaka, Satoshi Soen, Shintaro Hirata, et al.
Clinical Rheumatology|April 1, 2026
Clinical outcomes of molecular-targeted therapies for rheumatoid arthritis: comparison between orthopaedic surgeons and rheumatologists in the multicenter retrospective ANSWER cohortYuki Etani, Yasutaka Okita, Kohei Tsujimoto, et al.
Scientific Reports|January 8, 2022
Factors affecting drug retention of Janus kinase inhibitors in patients with rheumatoid arthritis: the ANSWER cohort studyKosuke Ebina, Toru Hirano, Yuichi Maeda, et al.
Pageof 16